Wimal Pathmasiri, PhD
Assistant Professor of Nutrition, Sumner Lab
wimal_pathmasiri@unc.edu
(704) 250-5069 office
(919) 951-4086 mobile
View CV
Wimal Pathmasiri, PhD is an Assistant Professor at the University of North Carolina at Chapel Hill’s Nutrition Research Institute (NRI). An overarching goal of Dr. Pathmasiri’ s research includes understanding the links between exposures (diet, constituents in natural projects, environmental chemicals, drugs), microbial metabolism, and human health. He has worked with the Sumner-Lab for over 12 years, as the director of a technology core for the NIH Common Fund Eastern Regional Comprehensive Metabolomics Resource Core (ERCMRC) and works as a co-investigator in the North Carolina Human Health Exposure Analysis Resource Untargeted Analysis Laboratory (NC HHEAR UAL). Dr. Pathmasiri develops and applies metabolomics to reveal metabolic pathway perturbations associated with disease states, therapeutic treatments, and environmentally relevant exposures. He has contributed to research in the areas of cancer, childhood obesity, early-life exposure to antibiotics, environmental exposure, kidney disease, osteoarthritis, rare diseases, and toxicology. Dr. Pathmasiri earned a BSc and MPhil from the University of Colombo, Sri Lanka, and a Licentiate of Philosophy from the Uppsala University, Sweden. He earned a PhD in Chemistry from Uppsala University and conducted postdoctoral research at UNC Chapel Hill, and at RTI International.
Collaboration Team


Blake R. Rushing, PhD
Assistant Professor of Nutrition, Sumner Lab
blake_rushing@unc.edu
704-250-5067


Publications
2020
Analysis of NMR Metabolomics Data.
2019
2018
Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity.
Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue.
2017
Effect of endotoxin and alum adjuvant vaccine on peanut allergy.
Neonatal Metabolomic Profiles Related to Prenatal Arsenic Exposure.
2016
A General Method for Targeted Quantitative Cross-Linking Mass Spectrometry.
Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice.
Impact of a western diet on the ovarian and serum metabolome.